VEGFA and neoplasm: This effect can enhance the systemic delivery of cytotoxic drugs, immunotherapy, and improve tumour radiosensitivity [102,105] The concept was elegantly demonstrated by Lee and colleagues for RT, where an enhanced tumour response was observed by combining radiation with an anti-VEGF monoclonal antibody [106].